Corporate
News coverage on GSK
August 26, 2025
GSK Pharma re-enters oncology market
Source : The Times of India
August 26, 2025
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers
Source : BW Healthcare World
August 26, 2025
Why Jemperli and Zejula will be key assets in GSK’s India oncology portfolio?
Source : Business Today
August 26, 2025
GSK India Oncology Second Innings: Can Jemperli, Zejula Set The Pace?
Source : SCRIP Citeline Commercial
August 25, 2025
GSK enters into oncology segment; launches therapies for gynaecological cancers
Source : Press Trust Of India
August 25, 2025
GSK re-enters India's cancer drug market
Source : The Economic Times
August 25, 2025
GSK India re-enters oncology segment with launch of Jemperli and Zejula
Source : Business Standard
August 25, 2025
GSK re-enters cancer drugs segment with two gynaecology drugs
Source : The Hindu BusinessLine
August 25, 2025
GSK To Launch Jemperli & Zejula Drugs In India To Treat Gynaecological Cancers
Source : CNBC TV18 - YouTube
August 25, 2025
GSK re-enters India's oncology market with Jemperli and Zejula, unveils tiered pricing and patient support program
Source : Moneycontrol
August 25, 2025
GSK introduces Jemperli and Zejula in India to expand oncology portfolio
Source : Express Pharma
August 25, 2025
GSK Enters Oncology in India with Jemperli and Zejula
Source : Sakshi
August 25, 2025
जीएसके ने ‘ऑन्कोलॉजी’ क्षेत्र में किया प्रवेश; स्त्री रोग संबंधी कैंसर के लिए उपचार शुरू किया
Source : ThePrint Hindi
February 27, 2025
AstraZeneca, Bayer, Eli Lilly: Why global pharma giants are betting big on India’s healthcare revolution
Source : Fortune India
January 4, 2025
GSK marks century in India with commemorative ₹5 stamp
Source : The Hindu BusinessLine
January 4, 2025
Released Customized My Stamp and Special Postal Cover commemorating the 100 years of GlaxoSmithKline Pharmaceuticals Ltd.
Source : X.Com
